In an interview with CNN’s chief medical correspondent Sanjay Gupta, Baurla said he first got information about the results of the hearing on Sunday and he has not seen the data yet, casting cold water on the idea that voters have no political motive behind releasing the news. Choose their candidate for president in the United States.
Gupta reported that Pfizer took a lot of interim look at the data during its vaccine trial, but the test group was not infected enough to get any meaningful data – Gupta reported. If anything, the data came earlier than expected: In October, Bourla commented in an open letter on Pfizer’s website, “Based on our current trial registration and dosing momentum, we anticipate we will reach the third week of this landmark. November. “
The Trump administration was quick to take credit for Pfizer’s promising news. Vice President Mike Pence
Tweeted Pfizer’s development is “thanks to a public-private partnership created by President Donald Trump.”
Yet Pfizer was not part of the Trump administration’s “War Operation War Speed”, which encouraged pharmaceutical companies to increase the development of their coronavirus vaccines.
The US federal government pledged $ 1.95 billion Pfizer (P.F.E.) And partner Biotech (BNTX) Once the vaccine is ready to assist in its distribution – but the government is not directly assisting in its development.
Trump called on drug companies to push for new developments ahead of election day. He made it clear to the CEOs of the companies that some of their health advisers wanted to move a vaccine faster than was reasonable.
Monday morning, President-elect Joe Biden
Issued a statement “Excellent news” is welcome and “brilliant women and men who helped make this progress.”
He added that “it is also important to understand that the fight against Covid-19 is still months away” and that “there will be many more months before comprehensive vaccinations take place in the United States.”
National Institute of Allergy and Infectious Diseases Director Dr. Anthony Fawcett said the news of Pfizer’s vaccine affects other Covid-19 vaccines of development, adding that Pfizer is able to get results quickly due to the severity of the epidemic.
Vaccination
Although the vaccine is not set to be widely administered anytime soon, Pfizer said the U.S. would be vaccinated immediately after a second dose of the vaccine was monitored by volunteers for two months. Emergency use is planned to be approved by the Food and Drug Administration.
Pfizer has at least three vaccine manufacturing sites in the United States, Gupta said. In Kamimazu, Michigan, at the facility, there are many refrigerators – spread out about the length of a football field – used to store vaccines.
For months companies have been rushing to develop and eventually distribute effective coronavirus vaccines. Companies continue to move vaccine candidates through clinical trials, moving closer to determining what would be considered safe and effective, showing no sign of slowing down in this race.
Vaccines by Pfizer and Moderna use new technology that has never been used before in vaccines, and experts say there is a reason to be cautious on your own.
While the development means progress is being made, they will do little to reduce the coronavirus winter surge in the short term, although it will be appropriate in 2021 before the dose becomes available to all Americans.
CNN’s Maggie Fox, Sara Murray and Kevin Liptk contributed to the report.
.
Related
